Vetr upgraded shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) from a hold rating to a buy rating in a research report released on Thursday morning. They currently have $1,020.34 target price on the medical equipment provider’s stock.
Several other research firms have also recently weighed in on ISRG. Zacks Investment Research upgraded Intuitive Surgical from a hold rating to a buy rating and set a $911.00 price objective on the stock in a report on Monday, April 24th. Barclays PLC reiterated a buy rating and set a $830.00 price objective (up previously from $800.00) on shares of Intuitive Surgical in a report on Wednesday, April 19th. Stifel Nicolaus reiterated a buy rating and set a $1,100.00 price objective (up previously from $850.00) on shares of Intuitive Surgical in a report on Saturday, July 22nd. Leerink Swann reiterated an outperform rating on shares of Intuitive Surgical in a report on Wednesday, July 5th. Finally, Royal Bank Of Canada lifted their price objective on Intuitive Surgical from $800.00 to $950.00 and gave the company a sector perform rating in a report on Tuesday, July 18th. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Intuitive Surgical has an average rating of Buy and an average price target of $980.61.
Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 984.31 on Thursday. Intuitive Surgical has a 12-month low of $610.71 and a 12-month high of $993.00. The firm’s 50-day moving average price is $946.69 and its 200 day moving average price is $844.19. The firm has a market cap of $36.57 billion, a P/E ratio of 47.15 and a beta of 0.39. Intuitive Surgical’s stock is going to split on the morning of Thursday, August 31st. The 3-1 split was announced on Friday, August 11th. The newly created shares will be distributed to shareholders after the market closes on Wednesday, August 30th.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $5.79 by $0.16. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The business had revenue of $756.20 million for the quarter, compared to analysts’ expectations of $724.51 million. During the same quarter in the previous year, the business posted $5.62 EPS. Intuitive Surgical’s revenue for the quarter was up 12.8% on a year-over-year basis. On average, equities analysts expect that Intuitive Surgical will post $23.92 earnings per share for the current fiscal year.
In other Intuitive Surgical news, CEO Gary S. Guthart sold 17,975 shares of the business’s stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $937.27, for a total transaction of $16,847,428.25. Following the transaction, the chief executive officer now owns 101,798 shares of the company’s stock, valued at approximately $95,412,211.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Jamie Samath sold 242 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $949.01, for a total value of $229,660.42. Following the transaction, the vice president now directly owns 23 shares in the company, valued at approximately $21,827.23. The disclosure for this sale can be found here. Insiders have sold a total of 34,065 shares of company stock worth $31,659,090 in the last ninety days. Insiders own 2.50% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of ISRG. Brown Advisory Securities LLC raised its position in Intuitive Surgical by 1.4% in the first quarter. Brown Advisory Securities LLC now owns 2,247 shares of the medical equipment provider’s stock valued at $1,722,000 after buying an additional 31 shares during the period. Vident Investment Advisory LLC raised its position in Intuitive Surgical by 137.0% in the first quarter. Vident Investment Advisory LLC now owns 9,572 shares of the medical equipment provider’s stock valued at $7,337,000 after buying an additional 5,534 shares during the period. Marshall Wace North America L.P. bought a new position in Intuitive Surgical during the first quarter valued at $9,596,000. Credit Suisse AG raised its position in Intuitive Surgical by 12.1% in the first quarter. Credit Suisse AG now owns 111,246 shares of the medical equipment provider’s stock valued at $85,268,000 after buying an additional 11,965 shares during the period. Finally, Biondo Investment Advisors LLC raised its position in Intuitive Surgical by 9.8% in the first quarter. Biondo Investment Advisors LLC now owns 32,652 shares of the medical equipment provider’s stock valued at $21,596,000 after buying an additional 2,922 shares during the period. 96.08% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.